PNXP · PINEAPPLE EXPRESS CANNABIS Co
Market Cap
$21,298
Shares
42.60M
PNXP metrics
44 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$21,298
Price action
19 metricsPrice change (1W)
-28.6%
Price change (30D)
-44.4%
Price change (3M)
-70.6%
Price change (6M)
-88.9%
Price change (YTD)
-91.7%
Price change (1Y)
-90.9%
Trailing year
Price change (5Y)
—
52-week high
$0.01
52-week low
$0.00
Change from 52-week high
-93.9%
Change from 52-week low
+0.0%
Annualized volatility
432.1%
Beta
0.3
RSI (14D)
35.4
Price vs SMA 50
-50.6%
Price vs SMA 200
-79.9%
Avg volume (3M)
2.52M
Relative volume
2.5
Average dollar volume
$2,570
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
42.60M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
0.0
reciprocal yield 4,251.0%
Earnings yield
-3,064.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$336,255
Net income (TTM)
−$652,757
Trailing 12 months
Diluted EPS (TTM)
$-0.02
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-2.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+27.8%
Revenue CAGR (5Y)
-17.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-343.6%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Cash & equivalents
$0
Total assets
$190,000
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$905,386
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
25 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—